Poultry Vaccine Market: By Vaccine (Inactivated Vaccines, Live Attenuated Vaccines, and Others), By Application (Mareka's Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Influenza, Coccidiosis, Mycoplasma, and Others), and Geography.   

Purchase Option

$ 4400
$ 6600
$ 8900

poultry vaccine market size was valued at USD 2299.8 million in 2022 and is expanded to grow at a significant CAGR of 5.9% over 2023-2029. The disease outbreaks in poultry drive the poultry vaccine market. Growing farmed poultry can speed up the spread of infectious pathogens among birds, such as the avian influenza virus, which has the great promise to cause widespread mortality and significant economic losses in poultry. However, poultry is accepted as a good source of protein. The poultry industry will be forced to intensify production in many countries, leading to more significant numbers of farms that house birds at elevated densities. Hence the regulatory bodies are accelerating the approval process for various vaccines related to veterinary health. Increasing awareness among veterinary practitioners about animal vaccination, growing meat consumption, and rising government initiatives for food safety is boosting the market. The growing poultry population, combined with the rising prevalence of avian diseases, will also drive market growth in the coming years.

Moreover, infected meat consumption risks human health, thereby making it imperative that the birds be vaccinated before usage. The main obstacles poultry farms face are the rapid spread of diseases and the lack of treatment options. To prevent such situations, vaccination becomes mandatory. In 2021, the attenuated live vaccines segment held the largest revenue share. Live attenuated vaccines' duration of immunity lasts longer and protects against avian diseases such as infectious bronchitis, infectious bursal disease, and Newcastle disease. Moreover, growing R&D activities, particularly in this field of vaccination, to curb various outbreaks of the diseases mentioned above are accentuating the segment growth.

Poultry Vaccine Market Key Developments:
  • In February 2021, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders.
  • In July 2020, Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health.
  • For instance, in April 2019, according to the Middle East Rating Agency, the Qatar government established central food laboratories with different procedures and analyses on food safety to ensure consumers are provided with contamination-free, safe, and high-quality meat products.

Poultry Vaccines Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Poultry Vaccines Market Dynamics

Across many parts of the world, the poultry industry is expanding and becoming more industrialized. Increased population, increased purchasing power, and urbanization have all been significant growth drivers. Furthermore, growing consumption of meat globally, initiatives are taken by the government, and increasing demand for poultry-related food products are the major factors driving the market's growth. Increasing use of antibiotics and illegal use of vaccines & backyard poultry will hamper the global industry.

Key Features of the Reports

  • The poultry vaccine market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Poultry Vaccines Market Segmentation

By Vaccine Type
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Others
By Application
  • Mareks Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Avian Influenza
  • Coccidiosis
  • Mycoplasma
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The poultry vaccine market size was valued at USD 2299.8 million in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary

2. Global Poultry Vaccines Market Introduction

2.1. Global Poultry Vaccines Market - Taxonomy
2.2. Global Poultry Vaccines Market -Definitions
2.2.1. Vaccine Type
2.2.2. Application
3. Global Poultry Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Poultry Vaccines Market Dynamic Factors - Impact Analysis
3.6. Global Poultry Vaccines Market - Regulations
3.6.1. U.S.
3.6.2. Europe
4. Global Poultry Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Poultry Vaccines Market Analysis, By Vaccine Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Live Attenuated Vaccines
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Recombinant Vaccines
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Poultry Vaccines Market Analysis, By Application, 2018 - 2022 and Forecast, 2023 - 2029
6.1. Marek's Disease
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Newcastle Disease
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Infectious Bursal Disease
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Infectious Bronchitis
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Poultry Vaccines Market Analysis, By Formulation, 2018 - 2022 and Forecast, 2023 - 2029
7.1. Dry Form (Duct) Vaccines
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Liquid Vaccines
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Freeze Dried Vaccines
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Poultry Vaccines Market Analysis, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Region, 2023 - 2029
9. North America Poultry Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Vaccine Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Inactivated Vaccines
9.1.2. Live Attenuated Vaccines
9.1.3. Recombinant Vaccines
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Marek's Disease
9.2.2. Newcastle Disease
9.2.3. Infectious Bursal Disease
9.2.4. Infectious Bronchitis
9.2.5. Others
9.3. Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Dry Form (Duct) Vaccines
9.3.2. Liquid Vaccines
9.3.3. Freeze Dried Vaccines
9.4. Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2023 - 2029
9.6. North America Poultry Vaccines Market Dynamics - Trends
10. Europe Poultry Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.1. Germany
10.1.2. UK
10.1.3. France
10.1.4. Spain
10.1.5. Italy
10.1.6. Russia
10.1.7. Poland
10.1.8. Rest of Europe
10.2. Europe Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2023 - 2029
10.3. Europe Poultry Vaccines Market Dynamics - Trends
11. Asia-Pacific Poultry Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. ASEAN
11.1.5. Australia & New Zealand
11.1.6. Rest of Asia-Pacific
11.2. Asia-Pacific Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2023 - 2029
11.3. Asia-Pacific Poultry Vaccines Market Dynamics - Trends
12. Latin America Poultry Vaccines Market Analysis, 2012 - 2012 - 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Argentina
12.1.4. Venezuela
12.1.5. Rest of Latin America
12.2. Latin America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2023 - 2029
12.3. Latin America Poultry Vaccines Market Dynamics - Trends
13. Middle East and Africa Poultry Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.1.1. Gulf Cooperation Council (GCC) Countries
13.1.2. Israel
13.1.3. South Africa
13.1.4. Rest of MEA
13.2. MEA Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2023 - 2029
13.3. MEA Poultry Vaccines Market Dynamics - Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
14.2.2. Merck & Co. Inc. (U.S)
14.2.3. Boehringer Ingelheim Vetmedica (Germany)
14.2.4. Elanco (U.S.)
14.2.5. Bayer Animal Health (Germany)
14.2.6. Ceva Sante Animale (France)
14.2.7. Indovax Pvt. Ltd. (India)
14.2.8. Hester Biosciences Limited. (India)
14.2.9. Zydus AHL (India)
15. Research Methodology
16. Key Assumptions and Acronyms
  • Merck & Co., Inc.,
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Biovac
  • Zoetis
  • Hester Biosciences Limited
  • KM Biologics
  • Phibro Animal Health Corporation

Adjacent Markets